Skip to search formSkip to main contentSkip to account menu

Levodopa

Known as: beta-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxy-L-phenylalanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine 
An amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
We assessed prospectively clinical and quality of life changes in 9 patients with Parkinson's disease (PD; H&Y ≥ 3) with severe… 
Highly Cited
1997
Highly Cited
1997
We studied anticipatory postural adjustments contributing to gait initiation deficits in patients with Parkinson's disease (PD… 
Highly Cited
1995
Highly Cited
1995
Abstract Objective: To compare effectiveness of levodopa and levodopa combined with selegiline in treating early, mild Parkinson… 
Highly Cited
1988
Highly Cited
1988
Daily cocaine injection into rodents produces a progressive increase in the motor stimulant effect of acute cocaine… 
Highly Cited
1979
Highly Cited
1979
In 520 patients with parkinsonism seen over eight years, 168 (32%) had moderate to marked dementia. Although the demented… 
Highly Cited
1966
Highly Cited
1966
Rats were depleted of tissue monoamines by reserpine treatment and were then treated with a monoamine-oxidase inhibitor…